Back to Market Feed

Product Information

LAMOTRIGINE ER 250 MG TABLET is a generic product labeled by Endo USA Inc., priced at $1.2532 per EA under NDC 49884060411. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Jan 18, 2013.

LAMOTRIGINE ER 250 MG TABLET

lamotrigine extended release
$1.2532per EA

Strength

250 mg/1

Manufacturer

Endo USA Inc.

NDC

49884060411

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LAMOTRIGINE

Approval Type

Generic (ANDA)

FDA Application

ANDA201791

FDA Approved

1/18/2013

On Market Since

1/18/2013

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Dihydrofolate Reductase Inhibitors
Mood Stabilizer
Organic Cation Transporter 2 Inhibitors

Price Statistics

The NADAC for LAMOTRIGINE ER 250 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 90.6%. The table below summarizes its recorded NADAC range and movement.

Current price$1.2532 per EA
All-time high$15.2970 (Aug 13, 2014)
All-time low$1.1070 (Nov 19, 2025)
52-week high$1.3127
52-week low$1.1070
Median price$8.3494
Average price$7.6212
Largest weekly change+56.5% (Aug 21, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

-1.9%

1M

-1.9%

3M

+0.4%

6M

-4.5%

1Y

+1.2%

3Y

-51.4%

5Y

-82.8%

All

-90.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lamotrigine extended release market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

GABAPENTIN 100 MG CAPSULE
Generic
00480349405•Teva Pharmaceuticals USA Inc.
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
00904666561•Major Pharmaceuticals
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086701•Rising Pharma Holdings Inc.
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086710•Rising Pharma Holdings Inc.
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16571086750•Rising Pharma Holdings Inc.
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066101•NorthStar Rx LLC
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
16714066102•NorthStar Rx LLC
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086601•Heritage Pharmaceuticals Inc.
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
23155086605•Heritage Pharmaceuticals Inc.
$0.0209
per EA
GABAPENTIN 100 MG CAPSULE
Generic
31722014801•Camber Pharmaceuticals Inc.
$0.0209
per EA

Frequently asked questions

What is the NADAC price of LAMOTRIGINE ER 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE ER 250 MG TABLET, manufactured by Endo USA Inc., is $1.2532 per EA (NDC 49884060411), effective Aug 19, 2026.

How has the price of LAMOTRIGINE ER 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for LAMOTRIGINE ER 250 MG TABLET has declined 90.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for LAMOTRIGINE ER 250 MG TABLET?

Since Nov 28, 2013, the NADAC for LAMOTRIGINE ER 250 MG TABLET has ranged from a low of $1.1070 (Nov 19, 2025) to a high of $15.2970 (Aug 13, 2014), with a median of $8.3494 per EA.

Are there cheaper alternatives to LAMOTRIGINE ER 250 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of LAMOTRIGINE ER 250 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures LAMOTRIGINE ER 250 MG TABLET?

LAMOTRIGINE ER 250 MG TABLET (NDC 49884060411) is labeled by Endo USA Inc., and CMS classifies it as a generic product.